Literature DB >> 20422060

Canadian Thoracic Society Asthma Committee commentary on long-acting beta-2 agonist use for asthma in Canada.

M Diane Lougheed1, Catherine Lemiere, Sharon Dell, Francine Ducharme, J Mark Fitzgerald, Richard Leigh, Chris Licskai, Brian H Rowe, Dennis Bowie, Allan Becker, Louis-Philippe Boulet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20422060      PMCID： PMC2866223          DOI： 10.1155/2010/378289

Source DB:  PubMed          Journal:  Can Respir J        ISSN： 1198-2241            Impact factor:   2.409


× No keyword cloud information.
  7 in total

Review 1.  Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003.

Authors:  Allan Becker; Catherine Lemière; Denis Bérubé; Louis-Philippe Boulet; Francine M Ducharme; Mark FitzGerald; Thomas Kovesi
Journal:  CMAJ       Date:  2005-09-13       Impact factor: 8.262

Review 2.  Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids.

Authors:  Pierre Ernst; Andrew McIvor; Francine M Ducharme; Louis-Philippe Boulet; Mark FitzGerald; Kenneth R Chapman; Tony Bai
Journal:  Ann Intern Med       Date:  2006-11-07       Impact factor: 25.391

Review 3.  Management of asthma in adults.

Authors:  Meyer S Balter; Alan D Bell; Alan G Kaplan; Harold Kim; R Andrew McIvor
Journal:  CMAJ       Date:  2009-09-28       Impact factor: 8.262

Review 4.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

5.  Canadian Thoracic Society Asthma Management Continuum--2010 Consensus Summary for children six years of age and over, and adults.

Authors:  M D Lougheed; C Lemière; S D Dell; F M Ducharme; J Mark Fitzgerald; R Leigh; C Licskai; B H Rowe; D Bowie; A Becker; Louis-Philippe Boulet
Journal:  Can Respir J       Date:  2010 Jan-Feb       Impact factor: 2.409

6.  The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol.

Authors:  Harold S Nelson; Scott T Weiss; Eugene R Bleecker; Steven W Yancey; Paul M Dorinsky
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

7.  Adult Asthma Consensus Guidelines update 2003.

Authors:  Catherine Lemière; Tony Bai; Meyer Balter; Charles Bayliff; Allan Becker; Louis-Philippe Boulet; Dennis Bowie; André Cartier; Andrew Cave; Kenneth Chapman; Robert Cowie; Stephen Coyle; Donald Cockcroft; Francine M Ducharme; Pierre Ernst; Shelagh Finlayson; J Mark FitzGerald; Frederick E Hargreave; Donna Hogg; Alan Kaplan; Harold Kim; Cheryle Kelm; Paul O'Byrne; Malcolm Sears; Andrea White Markham
Journal:  Can Respir J       Date:  2004 May-Jun       Impact factor: 2.409
  7 in total
  6 in total

1.  Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults.

Authors:  M Diane Lougheed; Catherine Lemiere; Francine M Ducharme; Chris Licskai; Sharon D Dell; Brian H Rowe; Mark Fitzgerald; Richard Leigh; Wade Watson; Louis-Philippe Boulet
Journal:  Can Respir J       Date:  2012 Mar-Apr       Impact factor: 2.409

2.  Canadian Thoracic Society 2012 guideline update: Diagnosis and management of asthma in preschoolers, children and adults: executive summary.

Authors:  M Diane Lougheed; Catherine Leniere; Francine M Ducharme; Chris Licskai; Sharon D Dell; Brian H Rowe; Mark FitzGerald; Richard Leigh; Wade Watson; Louis-Philippe Boulet
Journal:  Can Respir J       Date:  2012 Nov-Dec       Impact factor: 2.409

Review 3.  Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews.

Authors:  Christopher J Cates; Marta Oleszczuk; Elizabeth Stovold; L Susan Wieland
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

Review 4.  Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews.

Authors:  Christopher J Cates; L Susan Wieland; Marta Oleszczuk; Kayleigh M Kew
Journal:  Cochrane Database Syst Rev       Date:  2014-02-06

5.  Phosphodiesterase type 4D gene polymorphism: association with the response to short-acting bronchodilators in paediatric asthma patients.

Authors:  Malgorzata Labuda; Sophie Laberge; Julie Brière; Denis Bérubé; Patrick Beaulieu; Tomi Pastinen; Maja Krajinovic
Journal:  Mediators Inflamm       Date:  2011-08-24       Impact factor: 4.711

6.  Trends in asthma-related direct medical costs from 2002 to 2007 in British Columbia, Canada: a population based-cohort study.

Authors:  Pierrick Bedouch; Mohsen Sadatsafavi; Carlo A Marra; J Mark FitzGerald; Larry D Lynd
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.